• |
  • |
  • |
  • |
Donate

Product

Implications of Prenatal Testing for Down Syndrome video podcast

Center:
Fiscal Year:
2012
Contact Information:
Product Description:
Vanderbilt Kennedy Research Ethics Grand Rounds: It is now possible to receive a non-invasive prenatal test for Down syndrome that can be administered at 10 weeks of gestation and reportedly has 99% accuracy. As technology advances and allows for genetic tests such as MaterniT21 to be developed, what ethical considerations arise? Panelists: Robert Hodapp, Ph.D., Moderator, Professor of Special Education and Director of Research, Vanderbilt Kennedy Center UCEDD Frank Boehm, M.D., Professor of Obstetrics and Gynecology and Associate Professor of Radiology and Radiological Sciences; Martha Dudek, M.S., L.C.G.C., Genetic Counselor Senior Associate in Obstetrics and Gynecology Associate in Pediatrics; Christine Sartain, Parent advocate
Keyword(s):
Product/Publication Type(s):
Web-based products
Target Audience:
Professionals, Students
Alternative Format:
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A